Keywords: japan, daiichi, raises, full-year, forecast, despite, dip
Japan's Daiichi raises full-year forecast despite dip in nine-month net
Article | 14 February 2005
Japanese drugmaker Daiichi has reported favorable consolidated results for the first three quarters (April-December 2004) of the fiscal year to March 2005 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
